Helen of Troy stock last at USD 28.99 on October 16, 2026, 9.35 percent below 52-week high

Published on 10/17/2026 at 19:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UBS raised target to USD 29.00 on October 9, 2026. Helen of Troy stock was last at USD 28.99 on October 16, 2026, down 1.83 percent versus the Nasdaq close.

Analyst view and quarterly results

UBS raised its Helen of Troy target to USD 29.00 on October 9, 2026.
Second-quarter fiscal 2027 revenue reached USD 440.93 million, while adjusted earnings per share came to USD 0.79.
Helen of Troy stock was last at USD 28.99 on October 16, 2026, down 1.83 percent versus the Nasdaq prior close.
The company had a USD 678.1 million market capitalization on October 16, 2026.

HELE, BMG4388N1065, Illustration mit AI erstellt.

Helen of Troy stock was last at USD 28.99 on October 16, 2026 at 4:00 p.m. EDT on Nasdaq, down 1.83 percent versus the Nasdaq prior close. The share price stood 9.35 percent below its 52-week high of USD 31.98.

UBS target reaches USD 29.00

Investing.com reported on October 9, 2026 that UBS raised its target for Helen of Troy from USD 28.00 to USD 29.00 while maintaining a Neutral rating. The target sits 0.03 percent above the Nasdaq price of USD 28.99.

Second-quarter results add detail

For the second quarter of fiscal 2027 ended August 31, 2026, revenue reached USD 440.93 million and adjusted earnings per share came to USD 0.79, according to MarketBeat. The quarter included a USD 0.35 to USD 0.45 benefit from tariff refunds net of reinvestment, making the adjusted earnings figure materially different from an underlying quarter without that item.

The revenue figure was 0.32 percent below the USD 442.33 million analyst estimate cited by MarketBeat, while adjusted earnings per share exceeded the USD 0.50 estimate by USD 0.29. The contrast puts more weight on the quality and repeatability of the margin benefit than on sales alone.

Price position and valuation

Helen of Troy's 52-week range was USD 13.85 to USD 31.98 on October 16, 2026. Its market capitalization was USD 678.1 million, and its trailing price-to-earnings ratio was minus 6.65 on the same date. The company had no reported trailing dividend yield in the quoted market figures.

On October 8, 2026, Helen of Troy released its second-quarter fiscal 2027 results, and Business Wire said the company scheduled its related conference call for 9:00 a.m. ET that day. The next reporting date was not stated in the cited investor materials.

Comparison with peers

Helen of Troy (Nasdaq, USD): minus 1.83 percent, P/E minus 6.65, market capitalization USD 678.1 million.

Clorox (NYSE, USD): plus 1.03 percent, P/E 18.11, market capitalization USD 10.5 billion.

e.l.f. Beauty (NYSE, USD): minus 2.21 percent, P/E 113.51, market capitalization USD 6.7 billion.

What the figures indicate

Helen of Troy remains close to the upper end of its annual range despite the latest 1.83 percent decline. The valuation comparison is uneven: Clorox trades on a positive trailing earnings multiple, while Helen of Troy's negative ratio reflects its reported earnings base.

For investors, the key distinction is between the USD 0.79 adjusted earnings result and the USD 0.35 to USD 0.45 tariff-refund benefit. UBS's USD 29.00 target is only USD 0.01 above the October 16 Nasdaq price, leaving the analyst view tightly aligned with the market level.

Market position

Helen of Troy's last Nasdaq price was USD 28.99 on October 16, 2026 at 4:00 p.m. EDT, down 1.83 percent versus the Nasdaq prior close. The stock remained 9.35 percent below its USD 31.98 52-week high.